However, it is important to note that the stricter regulations and legal actions are necessary to combat the opioid crisis and reduce the number of addiction cases and overdose deaths. While the stock drop may have negative consequences for the pharmaceutical companies, it also highlights the urgent need for the industry to prioritize patient safety and public health over profits.